Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship
John M. McPartland · 2009
Read Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship by John M. McPartland (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005092.txt.
Description
Drug-company money has bent medical research before. Funded doctors have hyped pills and widened disease definitions. John McPartland examined that problem in one corner of medicine. His PLOS ONE paper appeared in 2009. The corner is obesity research on the endocannabinoid system. That system helps regulate appetite and weight.
The paper reviews the evidence while exposing sponsorship bias. It separates real findings from marketing-friendly claims. Academic physicians with industry funding helped enlarge the drug market, earlier research showed. This review asks which obesity claims survive scrutiny. It is a case study in following the money behind medicine. Readers learn to ask who paid before they believe.
Catalog record
| CREATOR | John M. McPartland |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005092